tradingkey.logo
tradingkey.logo
검색

Sol Gel Technologies Ltd

SLGL
관심 목록에 추가
74.010USD
+2.020+2.81%
종가 07/02, 13:00ET시세는 15분 지연됩니다
241.94M시가총액
손실P/E TTM

Sol Gel Technologies Ltd

74.010
+2.020+2.81%

자세한 내용은 Sol Gel Technologies Ltd 회사

Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

Sol Gel Technologies Ltd 정보

종목 코드 SLGL
회사 이름Sol Gel Technologies Ltd
상장일Feb 01, 2018
CEO- -
직원 수34
유형Ordinary Share
회계 연도 종료Feb 01
주소Golda Meir 7
도시NESS-ZIONA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Israel
우편 번호- -
전화97289313433
웹사이트http://www.sol-gel.com
종목 코드 SLGL
상장일Feb 01, 2018
CEO- -

Sol Gel Technologies Ltd의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Moshe (Mori) Arkin
Mr. Moshe (Mori) Arkin
Executive Chairman of the Board
Executive Chairman of the Board
143.26K
--
Mr. Ran Gottfried
Mr. Ran Gottfried
Lead Independent Director
Lead Independent Director
1.55K
--
Dr. Ofer Toledano, Ph.D.
Dr. Ofer Toledano, Ph.D.
Vice President - Research and Development
Vice President - Research and Development
--
--
Dr. Ofra Levy-Hacham, Ph.D.
Dr. Ofra Levy-Hacham, Ph.D.
Vice President - Clinical and Regulatory Affairs
Vice President - Clinical and Regulatory Affairs
--
--
Dr. Karine Neimann, Ph.D.
Dr. Karine Neimann, Ph.D.
Vice President - Projects and Planning, Chief Chemist
Vice President - Projects and Planning, Chief Chemist
--
--
Dr. Itzik Yosef, Ph.D.
Dr. Itzik Yosef, Ph.D.
Vice President - Operations
Vice President - Operations
--
--
Dr. Dubi (Dov) Zamir, Ph.D.
Dr. Dubi (Dov) Zamir, Ph.D.
Vice President - Special Projects
Vice President - Special Projects
--
--
Mr. Itai Arkin
Mr. Itai Arkin
Director
Director
--
--
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Independent Director
Independent Director
--
--
Ms. Hani Lerman
Ms. Hani Lerman
Director
Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Moshe (Mori) Arkin
Mr. Moshe (Mori) Arkin
Executive Chairman of the Board
Executive Chairman of the Board
143.26K
--
Mr. Ran Gottfried
Mr. Ran Gottfried
Lead Independent Director
Lead Independent Director
1.55K
--
Dr. Ofer Toledano, Ph.D.
Dr. Ofer Toledano, Ph.D.
Vice President - Research and Development
Vice President - Research and Development
--
--
Dr. Ofra Levy-Hacham, Ph.D.
Dr. Ofra Levy-Hacham, Ph.D.
Vice President - Clinical and Regulatory Affairs
Vice President - Clinical and Regulatory Affairs
--
--
Dr. Karine Neimann, Ph.D.
Dr. Karine Neimann, Ph.D.
Vice President - Projects and Planning, Chief Chemist
Vice President - Projects and Planning, Chief Chemist
--
--
Dr. Itzik Yosef, Ph.D.
Dr. Itzik Yosef, Ph.D.
Vice President - Operations
Vice President - Operations
--
--

자주 묻는 질문

Sol Gel Technologies Ltd의 상위 5대 주주는 누구인가요?

Sol Gel Technologies Ltd의 상위 5대 주주는 다음과 같습니다: Mr. Moshe (Mori) Arkin

Sol Gel Technologies Ltd(SLGL)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Sol Gel Technologies Ltd의 주식을 보유한 기관은 총 39곳이며, 이들이 보유한 주식의 총 가치는 약 1.00M로 전체 발행 주식의 30.93%를 차지합니다. 이는 2025Q4 대비 -175336.00 증가한 수치입니다.